期刊文献+

冠状动脉微血管功能障碍研究进展 被引量:6

Advances in Coronary Microvascular Dysfunction
下载PDF
导出
摘要 心外膜冠状动脉阻塞性疾病是公认的导致心绞痛的主要原因,然而近年来冠状动脉微血管功能障碍被认为是非阻塞性冠心病心肌缺血的主要机制。在微血管功能评估、治疗及其在心肌缺血方面的病理生理机制的研究已成为当今热点。 Obstructive disease of epicardial coronary arteries was recognized as the dominating cause of angina pectoris. In recent years, the dysfunction of coronary microvascular emerged as an primary mechanism of myocardial ischemia, however no obstructive coronary artery disease on angiography. The assessment of coronary mierovascular function, therapy, and the pathophysiologieal role of coronary microvascular dysfunction in the development of myocardial ischemia in different clinical conditions has become a hot issue.
出处 《心血管病学进展》 CAS 2017年第3期338-342,共5页 Advances in Cardiovascular Diseases
关键词 冠状动脉微血管 功能障碍 进展 Coronary microvascular Dysfuntion Advance
  • 相关文献

参考文献2

二级参考文献16

  • 1Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanisms and therapies.Eur Heart J,2001,22:729-739.
  • 2Galuto L.Optimal therapeutic strategies in the setting of post-infarct no reflow; the need for a pathogenetic classification.HEART,2004,90:123-125.
  • 3Kloner RA,Ganote CE,Jennings RB,The "no-reflow" phenomenon after temporary coronary occlusion in the dog.J Clin Invest,1974,54:1496-1508.
  • 4Byrne JG,Appleyard RF,Lee CC,et al.Controllde reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning,the no-reflow phenomenon,and infarct size.JThorac Cardiovasc Surg,1992,103:66-71.
  • 5Maekawa K,Kawamoto K,Fuke S,et al.Effects of intraaortic balloon pumping on the angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction.Circ J,2006,70(1):37-43.
  • 6Pasceri V,Patti G,Di Sciascio G.Prevention of myocardial damage during coronary intervention.Cardiovasc Hematol Disord Drug Targets,2006,6(2):77-83.
  • 7Iwakura K,Ito H,Kawano S,et al.Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction.Eur Heart J,2006,27 (5):534-539.
  • 8Zhao JL,Yang YJ,You SJ,et al.Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.Coron Artery Dis,2006,17 (5):463-469.
  • 9Porto I,Ashar V,Mitchell AR.Pharmacological management of no reflow during percutaneous coronary intervention.Curr Vasc Pharmacol,2006,4(2):95-100.
  • 10Reis SE, Holubkov R, Conrad Smith A J, et al. Coronary mierovascular dys- function is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study [ J ]. Am Heart J, 2001, 141 : 735-741.

共引文献20

同被引文献35

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部